TECH Bio-Techne Corp

$53.29

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/18/2025

About Bio-Techne Corp

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.

Website: https://www.bio-techne.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
June
CIK
842023
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN, US
Valuation
Market Cap
$7.60B
P/E Ratio
49.08
PEG Ratio
1.01
Price to Book
3.66
Performance
EPS
$0.98
Dividend Yield
0.67%
Profit Margin
13.20%
ROE
7.83%
Technicals
50D MA
$60.47
200D MA
$70.91
52W High
$85.29
52W Low
$46.44
Fundamentals
Shares Outstanding
158M
Target Price
$79.69
Beta
1.45

TECH EPS Estimates vs Actual

Estimated
Actual

TECH News & Sentiment

Aug 06, 2025 • Motley Fool NEUTRAL
Bio-Techne ( TECH ) Q4 EPS Rises 8.2%
Bio-Techne ( NASDAQ:TECH ) , a leading provider of life sciences tools and diagnostic solutions, reported its earnings for the fourth quarter of fiscal 2025 on August 6, 2025. The company's headline news was a modest beat on both revenue and non-GAAP earnings per share, with GAAP revenue of ...
Aug 06, 2025 • Zacks Commentary NEUTRAL
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.
Aug 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
TECH eyes modest Q4 growth as strong reagent and instrumentation demand offsets NIH and tariff concerns.
Jun 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.
Jun 19, 2025 • Benzinga SOMEWHAT-BULLISH
Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: Verified Market Research®
Lewes, Delaware, June 19, 2025 ( GLOBE NEWSWIRE ) -- The Global Exosome Research Market Size is projected to grow at a CAGR of 13.93% from 2026 to 2032, according to a new report published by Verified Market Research®.
May 30, 2025 • Benzinga SOMEWHAT-BULLISH
This PVH Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Commercial Metals ( NYSE:CMC ) , Brixmor Property Group ( NYSE:BRX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Tom Nikic initiated coverage on Columbia Sportswear Company COLM with a Hold ...
Sentiment Snapshot

Average Sentiment Score:

0.220
50 articles with scored sentiment

Overall Sentiment:

Bullish

TECH Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Jan 30, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.42
  • Estimate: $0.39
  • Whisper:
  • Surprise %: 7.8%
Oct 30, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.42
  • Estimate: $0.38
  • Whisper:
  • Surprise %: 10.5%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.49
  • Whisper:
  • Surprise %: 0.0%
May 01, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.48
  • Estimate: $0.45
  • Whisper:
  • Surprise %: 6.7%
Feb 01, 2024
Dec 31, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.40
  • Estimate: $0.41
  • Whisper:
  • Surprise %: -2.4%
Oct 31, 2023
Sep 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.44
  • Whisper:
  • Surprise %: -6.8%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.55
  • Whisper:
  • Surprise %: 0.0%
May 03, 2023
Mar 31, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.53
  • Whisper:
  • Surprise %: 0.0%

Financials